Robert Williams, Jr. Sells 10,000,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 10,000,000 shares of the stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total value of $90,000,000.00. Following the transaction, the insider directly owned 386,284 shares in the company, valued at approximately $3,476,556. This represents a 96.28% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 3.4%

Shares of Aveanna Healthcare stock opened at $9.43 on Friday. The business’s 50 day simple moving average is $8.49 and its 200-day simple moving average is $6.15. The stock has a market capitalization of $1.97 billion, a price-to-earnings ratio of 117.88 and a beta of 2.05. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.67 and a twelve month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The business had revenue of $450.53 million for the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%. Sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on AVAH shares. Barclays upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. Royal Bank Of Canada raised their target price on Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a research report on Friday. Weiss Ratings restated a “hold (c)” rating on shares of Aveanna Healthcare in a research report on Friday. Zacks Research cut Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. Finally, JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and raised their target price for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. Three analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $8.36.

Institutional Trading of Aveanna Healthcare

Several institutional investors have recently modified their holdings of AVAH. State of Alaska Department of Revenue bought a new position in Aveanna Healthcare during the third quarter valued at about $106,000. SG Americas Securities LLC bought a new stake in shares of Aveanna Healthcare during the 3rd quarter worth $153,000. Moran Wealth Management LLC bought a new stake in shares of Aveanna Healthcare during the 3rd quarter worth $201,000. KLP Kapitalforvaltning AS boosted its stake in shares of Aveanna Healthcare by 101.3% during the 3rd quarter. KLP Kapitalforvaltning AS now owns 15,500 shares of the company’s stock worth $137,000 after acquiring an additional 7,800 shares in the last quarter. Finally, CWM LLC boosted its position in shares of Aveanna Healthcare by 3,154.1% in the third quarter. CWM LLC now owns 15,522 shares of the company’s stock worth $138,000 after buying an additional 15,045 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.